Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

Pages

11899 items
4:29 PM, Feb 23, 2018  |  BC Extra | Financial News

HKEX reiterates plans to expand listing eligibility for biotechs

Hong Kong Exchanges and Clearing Ltd. (HKEX) published Friday the second round of its consultation paper proposing to amend listing rules to allow pre-revenue biotechs and companies from emerging and innovative sectors with weighted voting...
12:03 PM, Feb 22, 2018  |  BC Extra | Financial News

Ascendis, Aimmune price upsized follow-ons

Endocrinology company Ascendis Pharma A/S (NASDAQ:ASND) and allergy play Aimmune Therapeutics Inc. (NASDAQ:AIMT) raised a total of $401 million late Wednesday in bumped-up follow-ons. Ascendis raised $225 million through the sale of 3.9 million ADSs at...
3:02 AM, Feb 22, 2018  |  BC Extra | Financial News

Kallyope raises $66M in series B

Kallyope Inc. (New York, N.Y.) raised $66 million in a series B round. Existing investors Lux Capital, The Column Group, Polaris Partners, Illumina Ventures and Alexandria Venture Investments participated, as did new investors Euclidean Capital...
1:51 PM, Feb 21, 2018  |  BC Extra | Financial News

Oric raises $50M series C

Oric Pharmaceuticals Inc. (South San Francisco, Calif.) raised $50 million in a series C round from new investors Fidelity Management & Research, Trinitas Capital, Taiho Ventures and NS Investment. Existing investors, including The Column Group,...
8:41 AM, Feb 20, 2018  |  BC Extra | Financial News

Taiwan Liposome planning NASDAQ listing

Taiwan Liposome Co. Ltd. (TPEx:4152) proposed to raise up to $50 million through the sale of ADSs in a NASDAQ listing underwritten by Cantor Fitzgerald, CLSA, H.C. Wainwright, Janney Montgomery Scott and Laidlaw. The company...
4:20 PM, Feb 16, 2018  |  BC Extra | Financial News

Addex proposes CHF40M private placement

Addex Therapeutics Ltd. (SIX:ADXN) proposed Thursday to raise up to CHF40 million ($42.7 million) through the sale of 12.8 million shares at CHF3.43 in a private placement. The company said CHF30 million of the offering...
4:08 PM, Feb 16, 2018  |  BC Extra | Financial News

Alkermes hits high following IL-2 deal

Alkermes plc (NASDAQ:ALKS) hit a 52-week high of $71.22 on Friday on the heels of Wednesday's multibillion dollar deal between Nektar Therapeutics (NASDAQ:NKTR) and Bristol-Myers Squibb Co. (NYSE:BMY) involving NKTR-214. A note from Jefferies analyst...
10:08 AM, Feb 16, 2018  |  BC Extra | Financial News

Amicus raises $300M in bumped-up follow-on

Amicus Therapeutics Inc. (NASDAQ:FOLD) raised $300 million through the sale of 19.4 million shares at $15.50 in an upsized follow-on underwritten by J.P. Morgan, Goldman Sachs, Cowen, Leerink and BofA Merrill Lynch. The price is...
2:43 PM, Feb 15, 2018  |  BC Extra | Financial News

Consonance Capital promotes Pyun to partner

Consonance Capital Management promoted Kevin Pyun to partner and director of research. He was the fund's primary investment analyst....
2:21 PM, Feb 15, 2018  |  BC Extra | Financial News

Pontifax leads Abac’s €16M series A round

Abac Therapeutics S.A. (Barcelona, Spain) raised €16 million ($19.6 million) in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital Risc and Debiopharm Innovation Fund participated, as did existing...

Pages